Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata involves immune response and gene changes affecting hair loss.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.

The combination of cyclosporine and PUVA might help treat severe alopecia areata.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

Chronic kidney disease can cause skin problems that affect patient quality of life, and treating these conditions can improve outcomes.

Ultraviolet rays damage hair, smoking may cause hair loss, and good nutrition is important for hair health, but genetics mainly decide hair thickness.

Proper education can prevent traction alopecia in women of color.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

A patient with Satoyoshi syndrome improved with a treatment combining several medications, including carbamazepine and methotrexate.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Intralesional corticosteroids work best for mild alopecia areata, and DPCP works best for moderate to severe cases.

Thalidomide works best for skin lupus not helped by antimalarials, but has many side effects; other treatments are less effective, especially if patients also have systemic lupus.

Hormone imbalances can cause skin diseases, and understanding these links is important for diagnosis and treatment.

Most kidney transplant patients in the study had skin problems, often related to infections, medication side effects, or skin cancer risks.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

Some people with severe, long-lasting baldness responded well to a specific combination treatment.

Inhaled steroids in children may cause excessive hair growth and not always go away after stopping the medication.

Cyclosporine combined with corticosteroids is more effective for severe alopecia areata than cyclosporine alone.

Scalp involvement is common in pemphigus and can lead to hair loss, with the severity of scalp lesions linked to overall disease severity.

Healthcare providers need better understanding and cultural sensitivity to improve care for transgender patients with kidney failure needing transplants.

An 84-year-old man got a rare scalp condition from using imiquimod cream, which was cured with systemic steroids.

A mother and daughter with similar hair loss conditions and identical HLA types suggest a genetic link between the conditions.

Antiviral medication valganciclovir may improve skin and hair in Trichodysplasia Spinulosa patients.

A rare benign skin tumor showed unusual features of sebaceous and sweat glands, important for correct diagnosis.

Tip cryotherapy effectively treats idiopathic guttate hypomelanosis with minimal side effects.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.